Caplacizumab is considered among the advanced medications available for the management of thrombotic thrombocytopenic purpura and thrombosis. This FDA approved drug is known for its mechanism of action of blocking platelet aggregation. It helps in minimizing the organ injury caused by a condition called ischemia. Globally, this medication is known as Cablivi, which is the trade name for Caplacizumab. Developed by Ablynx NV, it is available as Cablivi 11mg/single-dose vial. Caplacizumab cost in India is determined by the global factors.
Cablivi (Caplacizumab) – US FDA and EMA Approval Status
Caplacizumab was granted the US FDA approval in 2019. It was precisely approved for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adult patients. It is a rare autoimmune disease or condition that requires specialized approach with advanced options. Being considered as a first-in-class medication, it has the advantage over the prevailing treatment protocols. Cablivi received its EMA approval in 2018, prior to the US FDA’s nod.
- Cablivi in India is relevant for patients who are assessed to benefit from it. The prevailing FDA and EMA approvals can form the basis for using such medications as they are backed by the clinical research data.
- Physicians treating aTTP prescribe Caplacizumab in India. Their recommendations are based on the existing research data as well as the emerging data from the ongoing trials and studies.
Cablivi India – Information regarding the access and commercial availability
Cablivi cost in India is an obvious point of discussion. But, it can be dealt with after understanding the process to source it. Hematologists are authorized to prescribe this product and it can be imported based on their recommendation. Deliberations about Caplacizumab price in India can be made once the quantity requirement is clear. While making a legal import of this medicine, it is important to notice that the license can be obtained only for an individual patient. Even though there are several limitations from the perspective of Indian patients, it turns out to be simple when the due procedures are followed. Sourcing through official channels can also ensure the quality is trusted. Ultimately patients should focus on experiencing the maximum clinical benefits. Usually the sources recommended by the treating physicians can be relied upon. Patients can search for online references in the absence of clear reference from Hospital pharmacies. Extensive validation is advised in such cases.
Convenient Sourcing of Caplacizumab in India
Medicines that are unavailable in India can be imported for personal use. CDSCO is the Indian agency that regulates the same. Patients recommended for using Cablivi (Caplacizumab) in India can follow the online process to get import permit, which is a mandatory requirement. It is also a better idea to take the help of experts who are well-versed with the processes. Any import process has its own timelines depending on the availability of medicines and the logistics arrangements. Accordingly, patients are advised to work on their import requirements and simultaneously plan their treatment schedules. It is better to source specialty medicines in adequate quantities. When it comes to the lifesaving medicines like Cablivi, the choice of service provider always matters the most. Work with only genuine sources that are known for their reputation. Companies with enough experience of handling requirements for Indian patients will naturally provide hassle-free solutions.
Contact Noel Biotech – +91 9677010046 / +91 992977766; firstname.lastname@example.org